We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$582M
AUM Growth
+$172M
Cap. Flow
+$166M
Cap. Flow %
28.59%
Top 10 Hldgs %
56.7%
Holding
46
New
13
Increased
16
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$37.8M
2
LH icon
Labcorp
LH
+$30.8M
3
NVRO
NEVRO CORP.
NVRO
+$24.6M
4
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$23.9M
5
BDX icon
Becton Dickinson
BDX
+$20.8M

Top Sells

Rank Stock Value
1
KND
Kindred Healthcare
KND
+$24.3M
2
SNY icon
Sanofi
SNY
+$23.7M
3
LLY icon
Eli Lilly
LLY
+$22.3M
4
STJ
St Jude Medical
STJ
+$12.3M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 81.08%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
26
DELISTED
Express Scripts Holding Company
ESRX
$8.3M 1.42%
+93,300
New +$8.15M
ACHN
27
DELISTED
Achillion Pharmaceuticals
ACHN
$7.76M 1.33%
876,000
+566,100
+183% +$5.35M
PMC
28
DELISTED
PharMerica Corporation
PMC
$7.63M 1.31%
229,214
-47,500
-17% -$1.46M
FOMX
29
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$7.25M 1.25%
707,449
+138,900
+24% +$1.54M
TVTX icon
30
Travere Therapeutics
TVTX
$5.27B
$6.95M 1.19%
209,500
-269,400
-56% -$7.38M
XENT
31
DELISTED
Intersect ENT, Inc
XENT
$6.69M 1.15%
233,757
+190,830
+445% +$5M
ITCI
32
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.15M 0.89%
161,300
+11,200
+7% +$284K
AGN.PRA
33
DELISTED
Allergan plc
AGN.PRA
$5.12M 0.88%
+4,900
New +$5.13M
ADYX
34
DELISTED
Adynxx Inc
ADYX
$4.32M 0.74%
13,660
+9,277
+212% +$2.74M
RIGL icon
35
Rigel Pharmaceuticals
RIGL
$693M
$3.78M 0.65%
117,649
-83,980
-42% -$3.21M
TLPH icon
36
Talphera
TLPH
$63.8M
$3.38M 0.58%
39,919
-12,115
-23% -$948K
VXRT
37
DELISTED
Vaxart
VXRT
$3.35M 0.57%
147,045
+13,290
+10% +$326K
SPNC
38
DELISTED
Spectranetics Corp
SPNC
$3.23M 0.55%
+140,400
New +$3.92M
AVDL
39
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-225,351
Closed -$4.05M
ENTA icon
40
Enanta Pharmaceuticals
ENTA
$371M
– –
-154,300
Closed -$4.72M
LLY icon
41
Eli Lilly
LLY
$1.09T
– –
-306,500
Closed -$22.3M
SNY icon
42
Sanofi
SNY
$108B
– –
-479,412
Closed -$23.7M
PFNX
43
DELISTED
Pfenex Inc.
PFNX
– –
-52,300
Closed -$834K
MNTA
44
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-695,016
Closed -$10.6M
ACT.PRA
45
DELISTED
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
– –
-4,900
Closed -$4.96M
RPRX
46
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-244,006
Closed -$2.1M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Senzar Asset Management held 46 positions worth $582M, up 42% from $410M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Senzar Asset Management deployed $166M of net new capital in Q2 2015, opening 13 new positions and adding to 16 existing holdings. Its largest new stake was Perrigo: 198,100 shares worth $36.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 83% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Kindred Healthcare, an estimated $24.3M trimmed.

  • Senzar Asset Management's largest Q2 2015 buy was Perrigo: 198,100 shares worth $36.6M.
  • Senzar Asset Management added most to Labcorp in Q2 2015, an estimated $30.8M increase.
  • Senzar Asset Management's biggest Q2 2015 reduction was Kindred Healthcare, cutting an estimated $24.3M.
  • Senzar Asset Management fully exited Sanofi in Q2 2015, selling an estimated $23.7M.
  • Senzar Asset Management's ten largest holdings make up 57% of its $582M portfolio in Q2 2015.
  • Senzar Asset Management opened 13 new positions and closed 8 in Q2 2015.
  • Senzar Asset Management's portfolio value rose 42% quarter-over-quarter to $582M.

Based on Senzar Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.